Discovery of potent, highly selective and orally efficacious SMARCA2 degraders

被引：0
|
作者：
Leng, Lingying
Yang, Lin
Tu, Wenbin
Rej, Rohan
Allu, Srinivasa Rao
Huang, Liyue
Jiang, Wei
Wang, Yu
Stuckey, Jeanne
Sarkari, Farzad R.
Wang, Meilin
Wang, Lu
Wen, Bo
Sun, Duxin
Wang, Shaomeng
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4506
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Discovery of YS-363 as a highly potent, selective, and orally efficacious EGFR inhibitor
    He, Pengxing
    Jing, Jing
    Du, Linna
    Zhang, Xuyang
    Ren, Yufei
    Yang, Han
    Yu, Bin
    Liu, Hongmin
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [12] Discovery of a potent and highly selective, orally efficacious IKK2 inhibitor for the treatment of rheumatoid arthritis
    Liddle, John
    Williamson, Rick A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [13] Potent SMARCA2 targeted degraders induce genetic synthetic lethality in SMARCA4 deleted cancer.
    Ito, Koichi
    Agarwal, Anjana
    Pitis, Philip
    Wang, Min
    Carter, Jack
    Cowart, Miles
    Dai, Chaofeng
    Gowen-MacDonald, William
    Elliot, Eliza
    Vidal, Brian
    Spruance, Jacob
    Tang, Hsin-Yao
    Ruggeri, Bruce
    Lu, Liang
    Combs, Andrew
    Lin, Hong
    Scherle, Peggy
    Vaddi, Kris
    CANCER RESEARCH, 2021, 81 (13)
  • [14] Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
    Jennifer Cantley
    Xiaofen Ye
    Emma Rousseau
    Tom Januario
    Brian D. Hamman
    Christopher M. Rose
    Tommy K. Cheung
    Trent Hinkle
    Leofal Soto
    Connor Quinn
    Alicia Harbin
    Elizabeth Bortolon
    Xin Chen
    Roy Haskell
    Eva Lin
    Shang-Fan Yu
    Geoff Del Rosario
    Emily Chan
    Debra Dunlap
    Hartmut Koeppen
    Scott Martin
    Mark Merchant
    Matt Grimmer
    Fabio Broccatelli
    Jing Wang
    Jennifer Pizzano
    Peter S. Dragovich
    Michael Berlin
    Robert L. Yauch
    Nature Communications, 13
  • [15] Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor
    Liu, K
    Xu, LB
    Szalkowski, D
    Li, ZH
    Ding, V
    Kwei, G
    Huskey, S
    Moller, DE
    Heck, JV
    Zhang, BB
    Jones, AB
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3487 - 3494
  • [16] Bifunctional Compounds as SMARCA2 Degraders for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021,
  • [17] Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
    Cantley, Jennifer
    Ye, Xiaofen
    Rousseau, Emma
    Januario, Tom
    Hamman, Brian D.
    Rose, Christopher M.
    Cheung, Tommy K.
    Hinkle, Trent
    Soto, Leofal
    Quinn, Connor
    Harbin, Alicia
    Bortolon, Elizabeth
    Chen, Xin
    Haskell, Roy
    Lin, Eva
    Yu, Shang-Fan
    Del Rosario, Geoff
    Chan, Emily
    Dunlap, Debra
    Koeppen, Hartmut
    Martin, Scott
    Merchant, Mark
    Grimmer, Matt
    Broccatelli, Fabio
    Wang, Jing
    Pizzano, Jennifer
    Dragovich, Peter S.
    Berlin, Michael
    Yauch, Robert L.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [18] Potent and orally efficacious PROTAC degraders of estrogen receptor α (ER α )
    Rej, Rohan K.
    Chen, Zhixiang
    Acharyya, Ranjan K.
    Wu, Dimin
    Hu, Biao
    Xu, Guozhang
    Nagilla, Rakesh
    Metwally, Hoda
    Wang, Yu
    Wen, Bo
    Sun, Duxin
    Bai, Longchuan
    Wang, Shaomeng
    CANCER RESEARCH, 2024, 84 (06)
  • [19] Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 Hydrolase
    Thoma, Gebhard
    Markert, Christian
    Lueoend, Rainer
    Miltz, Wolfgang
    Spanka, Carsten
    Bollbuck, Birgit
    Wolf, Romain M.
    Srinivas, Honnappa
    Penno, Carlos A.
    Kiffe, Michael
    Gajewska, Monika
    Bednarczyk, Dallas
    Wieczorek, Grazyna
    Evans, Amanda
    Beerli, Christian
    Rohn, Till A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (23) : 16410 - 16425
  • [20] Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors
    Yang, Yaxi
    Zhang, Rukang
    Li, Zhaojun
    Mei, Lianghe
    Wan, Shili
    Ding, Hong
    Chen, Zhifeng
    Xing, Jing
    Feng, Huijin
    Han, Jie
    Jiang, Hualiang
    Zheng, Mingyue
    Luo, Cheng
    Zhou, Bing
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (03) : 1337 - 1360
12345